SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bosco & Crossy's stock picks,talk area -- Ignore unavailable to you. Want to Upgrade?


To: PuddleGlum who wrote (3477)6/26/2003 10:50:04 AM
From: Crossy  Read Replies (1) | Respond to of 37387
 
re: NasdaqNM - CGPI - $12.50 Collagenix Inc

Next pick of mine - PROFITABLE BIOTECH & PHARMA company. Active in dental & dermal markets..

Periostat trials going rather well, became profitable last year, EPS of $0.15-0.20 looks attainable per quarter down the road (if not immediately)

There's a convertible out there (Oaktree one of the holders) which converts at $9.70. This led to convertible arbitrage strategies in the $10-12 price range. Without this issue, the stock would probably be trading north of $20 already. However this is going to end soon if it hasn't stopped already. Will post more DD info on it. For a start see collagenex.com

Ratios look quite ok - PSR of 2.95 an interesting pipeline, it made the IBD biopharma top 10 list this week. Hidden in its many PR's is a STRONG LINK to Australia's enigmatic company EPITAN - the people that own the rights to that drug which produces artificial pigmentation in humans and animals - which is called MELANOTAN. Collagenex co-develops a topical formulation of this currently injectible-only drug by applying one of it's drug delivery technologies.
Since Epitan doesn't exactly have much cash to finance trials and development, chances are the agreement with CGPI will produce a nice future REVENUE STREAM for Collagenex in exchange for some upfront financing of any sort..

rgrds
CROSSY



To: PuddleGlum who wrote (3477)6/26/2003 11:41:19 AM
From: Crossy  Respond to of 37387
 
re: CRVU
someone is selling the stock - 30k - (probably selling short) at MARKET ORDERS - no news out. If it tanks further I will enlarge my position. Never seen such a move on so few shares..

rgrds
CROSSY